[Beta and alpha-adrenoceptor blockers in the planning of anti-hypertensive therapy: recommendations for general practice].
D000273:Adipose Tissue / Q000187:drug effects; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001682:Biological Availability; D004078:Dihydralazine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011224:Prazosin / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D004078:Dihydralazine; D011224:Prazosin
Beta- und Alpha-Adrenozeptorblocker im antihypertensiven Therapieplan: Empfehlungen für die Praxis.